Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 placebo-controlled dose-finding study of molidustat for anemia in non-dialysis chronic kidney disease
2013-001193-14Phase 2Completed
- Sponsor
- Bayer
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of molidustat in anemia of chronic kidney disease (6 arms), sponsored by Bayer. Primary endpoint: Change in local laboratory hemoglobin from baseline to the average during the last 4 weeks of treatment. Started Sep 2013; status: completed.
02
Drugs
molidustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on 2013-001193-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001193-14.